Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  CDK2/TRKA inhibitor PHA-848125 AC
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CDKO-125a-006, NCI-2014-02427, 2009-014338-79, NCT01011439
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CDKO-125a-007, NCI-2014-02428, NCT01301391
Start Over